Search
Achieve Life Sciences Inc
ACHVAdd to Watchlist
5.700USD
+0.400+7.55%
Close 06/25, 16:00（ET）Quotes delayed by 15 min
303.47MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-24The current earnings forecast score of Achieve Life Sciences Inc is 8.00, ranking 167 out of 388 in the Biotechnology & Medical Research industry. The average price target is 14.00, with a high of 25.00 and a low of 10.00.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
13.500
Target Price
+169.46%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Achieve Life Sciences Inc
ACHV
8
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Achieve Life Sciences Inc's price target?
Analysts forecast that Achieve Life Sciences Inc's price target is USD 14.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 10.00.
How have Achieve Life Sciences IncACHV's recent earnings per share performed?
The market expectation was USD -0.19, while Achieve Life Sciences IncACHV's earnings per share (EPS) for the previous quarter was USD -0.27. EPS for the next quarter is expected at USD -0.16.
What is the analyst rating for Achieve Life Sciences Inc?
Based on the ratings of Achieve Life Sciences Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
